Is Screening for Esophageal Pathology in Asymptomatic Patients Post-Treatment for Head and Neck Cancer Beneficial?
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00583934|
Recruitment Status : Completed
First Posted : January 2, 2008
Last Update Posted : July 13, 2010
|Condition or disease|
|Study Type :||Observational|
|Actual Enrollment :||19 participants|
|Official Title:||Is Screening for Esophageal Pathology in Asymptomatic Patients Post-Treatment for Head and Neck Cancer Beneficial?|
|Study Start Date :||September 2007|
|Primary Completion Date :||November 2009|
|Study Completion Date :||November 2009|
Those six months post treatment for head and neck cancer.
- Early detection of esophageal cancer or dysplasia in patients without symptoms, after treating their primary cancer, may improve their chances of being cured of a secondary disease.
Biospecimen Retention: Samples With DNA
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00583934
|United States, California|
|University of California Davis Medical Center|
|Sacramento, California, United States, 95817|
|Principal Investigator:||Gregory Farwell, MD||University of California, Davis|